Photodiagnosis and Photodynamic Therapy
Volume 4, Issue 2 , Pages 130-139 , June 2007

Effect of vehicles and esterification on the penetration and distribution of hypericin in the skin of hairless mice

  • Annelies Boiy

      Affiliations

    • Laboratory for Pharmaceutical Biology, Faculty of Pharmaceutical Sciences, K.U. Leuven, Herestraat 49, box 824, B-3000 Leuven, Belgium
    • ,
  • Rik Roelandts

      Affiliations

    • Photodermatology Unit, University Hospital, Kapucijnenvoer 33, Leuven, Belgium
    • ,
  • Tania Roskams

      Affiliations

    • Department of Histochemistry and Cytochemistry, Faculty of Medicine, K.U. Leuven, Minderbroedersstraat 12, Leuven, Belgium
    • ,
  • Peter A.M. de Witte, PhD

      Affiliations

    • Laboratory for Pharmaceutical Biology, Faculty of Pharmaceutical Sciences, K.U. Leuven, Herestraat 49, box 824, B-3000 Leuven, Belgium
    • Corresponding Author InformationCorresponding author. Tel.: +32 16 323432; fax: +32 16 323460.

References 

  1. Kopp B. Hypericum perforatum L., St. John's Wort, a medicinal plant in folk medicine. Wien Med Wochenschr. 1999;149:190
  2. Meruelo D, Lavie G, Lavie D. Therapeutic agents with dramatic antiretroviral activity and little toxicity at effective doses: aromatic polycyclic diones hypericin and pseudohypericin. Proc Natl Acad Sci USA. 1988;85:5230–5234
  3. Avato P, Raffo F, Guglielmi G, Vitali C, Rosato A. Extracts from St. John's Wort and their antimicrobial activity. Phytother Res. 2004;18:230–232
  4. Suzuki O, Katsumata Y, Oya M, Bladt S, Wagner H. Inhibition of monoamine oxidase by hypericin. Plant Med. 1984;50:272–274
  5. Duran N, Song PS. Hypericin and its photodynamic action. Photochem Photobiol. 1986;43:677–680
  6. Lavie G, Mazur Y, Lavie D, Meruelo D. The chemical and biological properties of hypericin – a compound with a broad spectrum of biological activities. Med Res Rev. 1995;15:111–119
  7. Chung PS, Rhee CK, Kim KH, et al. Intratumoral hypericin and KTP laser therapy for transplanted squamous cell carcinoma. Laryngoscope. 2000;110:1312–1316
  8. Liu CD, Kwan D, Saxton RE, McFadden DW. Hypericin and photodynamic therapy decreases human pancreatic cancer in vitro and in vivo. J Surg Res. 2000;93:137–143
  9. Kamuhabwa AAR, Roskams T, D’Hallewin MA, Baert L, Van Poppel H, de Witte PAM. Whole bladder wall photodynamic therapy of transitional cell carcinoma rat bladder tumors using intravesically administered hypericin. Int J Cancer. 2003;107:460–467
  10. Lavie G, Mandel M, Hazan S, et al. Anti-angiogenic activities of hypericin in vivo: potential for ophthalmologic applications. Angiogenesis. 2005;8:35–42
  11. Morton CA, Brown SB, Collins S, et al. Guidelines for topical photodynamic therapy: report of a workshop of the British Photodermatology Group. Br J Dermatol. 2002;146:552–567
  12. Kurwa HA, Barlow RJ. The role of photodynamic therapy in dermatology. Clin Exp Dermatol. 1999;24:143–148
  13. Wolf P, Rieger E, Kerl H. Topical photodynamic therapy with endogenous porphyrins after application of 5-aminolevulinic acid. An alternative treatment modality for solar keratoses, superficial squamous cell carcinomas, and basal cell carcinomas?. J Am Acad Dermatol. 1993;28:17–21
  14. Peng Q, Warloe T, Moan J, et al. Distribution of 5-aminolevulinic acid-induced porphyrins in noduloulcerative basal cell carcinoma. Photochem Photobiol. 1995;62:906–913
  15. Calzavara-Pinton PG. Repetitive photodynamic therapy with topical delta-aminolaevulinic acid as an appropriate approach to the routine treatment of superficial non-melanoma skin tumours. J Photochem Photobiol B: Biol. 1995;29:53–57
  16. Chung PS, Saxton RE, Paiva MB, et al. Hypericin uptake in rabbits and nude mice transplanted with human squamous cell carcinomas: study of a new sensitizer for laser phototherapy. Lanryngoscope. 1994;104:1471–1476
  17. Chen B, de Witte PA. Photodynamic therapy efficacy and tissue distribution of hypericin in a mouse P388 lymphoma tumor model. Cancer Lett. 2000;150:111–117
  18. Schempp CM, Winghofer B, Langheinrich M, Schöpf E, Simon JC. Hypericin levels in human serum and interstitial skin blister fluid after oral single-dose and steady-state administration of Hypericum perforatum extract (St. John's Wort). Skin Pharmacol Appl Skin Physiol. 1999;12:299–304
  19. Kamuhabwa AR, Roelandts R, de Witte PA. Skin photosensitization with topical hypericin in hairless mice. J Photochem Photobiol B: Biol. 1999;53:110–114
  20. Kamuhabwa AR, Geboes KR, de Witte PA. Investigation of the absorption of hypericin into the skin of hairless mice. J Pharm Pharmacol. 2000;52:487–494
  21. Falk H, Meyer J, Oberreiter M. A convenient semisynthetic route to hypericin. Monatsh Chem. 1993;124:339–341
  22. Yamazaki T, Otha N, Yamazaki I, Song PS. Excited-state properties of hypericin: electronic spectra and fluorescence decay kinetics. J Phys Chem. 1993;97:7870–7875
  23. Huygens A, Kamuhabwa AR, Van Cleynenbreugel B, Van Poppel H, Roskams T, de Witte PA. In vivo accumulation of different hypericin ion pairs in the urothelium of the rat bladder. BJU Int. 2005;95:436–441
  24. Barry BW. Transdermal drug delivery. In:  Aulton ME editors. Pharmaceutics: the science of dosage form design. London: Harcourt Publishers Limited; 2002;p. 500–524
  25. Gloor M. How do dermatological vehicles influence the horny layer?. Skin Pharmacol Physiol. 2004;17:267–273
  26. Ogiso T, Iwaki M, Paku T. Effect of various enhancers on transdermal penetration of indomethacin and urea, and relationship between penetration parameters and enhancement factors. J Pharm Sci. 1995;84:482–488
  27. Rostrup-Nielsen T, Pedersen LS, Villadsen J. Thermodynamics and kinetics of lipase catalysed hydrolysis of oleyl oleate. J Chem Technol Biotechnol. 1990;48:467–482
  28. Menon GK, Grayson S, Elias PM. Cytochemical and biochemical localization of lipase and sphingomyelinase activity in mammalian epidermis. J Invest Dermatol. 1986;86:591–597
  29. Barry BW. Mode of action of penetration enhancers in human skin. J Control Release. 1987;6:85–97
  30. Moser K, Kriwet K, Naik A, Kalia YN, Guy RH. Passive skin penetration enhancement and its quantification in vitro. Eur J Pharm Biopharm. 2001;52:103–112
  31. Santoyo S, Arellano A, Ygartua P, Martin C. Penetration enhancer effects on the in vitro percutaneous absorption of piroxicam through rat skin. Int J Pharm. 1995;117:219–224
  32. Gwak HS, Chun IK. Effect of vehicles and penetration enhancers on the in vitro percutaneous absorption of tenoxicam through hairless mouse skin. Int J Pharm. 2002;236:57–64
  33. Agyralides GG, Dallas PP, Rekkas DM. Development and in vitro evaluation of furosemide transdermal formulations using experimental design techniques. Int J Pharm. 2004;281:35–43
  34. Mendelsohn R, Chen HC, Rerek ME, Moore DJ. Infrared microspectroscopic imaging maps the spatial distribution of exogenous molecules in skin. J Biomed Opt. 2003;8:185–190
  35. Pugh WJ, Roberts MS, Hadgraft J. Epidermal permeability – penetrant structure relationships: 3. The effect of hydrogen bonding interactions and molecular size on diffusion across the stratum corneum. Int J Pharm. 1996;138:149–165
  36. du Plessis J, Pugh MJ, Judefeind A, Hadgraft J. Physico-chemical determinants of dermal drug delivery: effects of the number and substitution pattern of polar groups. Eur J Pharm Sci. 2002;16:107–112
  37. Beisson F, Aoubala M, Marull S, et al. Use of the tape stripping technique for directly quantifying esterase activities in human stratum corneum. Anal Biochem. 2001;290:179–185
  38. Meyer W, Neurand K. Hydrolytic enzymes in the sebaceous glands of the domestic cat. Histochem J. 1976;8:639–646
  39. Hikima T, Yamada K, Kimura T, Maibach HI, Tojo K. Comparison of skin distribution of hydrolytic activity for bioconversion of β-estradiol 17-acetate between man and several animals in vitro. Eur J Pharm Biopharm. 2002;54:155–160
  40. Motwani MR, Rhein LD, Zatz JL. Influence of vehicles on the phase transitions of model sebum. J Cosmet Sci. 2002;53:35–42
  41. Motwani MR, Rhein LD, Zatz JL. Deposition of salicylic acid into hamster sebaceous. J Cosmet Sci. 2004;55:519–531
  42. Hongcharu W, Taylor CR, Chang Y, Aghassi D, Suthamjariya K, Anderson RR. Topical ALA-photodynamic therapy for the treatment of acne vulgaris. J Invest Dermatol. 2000;115:183–192
  43. Pollock B, Turner D, Stringer MR, et al. Topical aminolaevulinic acid – photodynamic therapy for the treatment of acne vulgaris: a study of clinical efficacy and mechanism of action. Br J Dermatol. 2004;151:616–622
  44. Yova D, Hovhannisyan V, Theodossiou T. Photochemical effects and hypericin photosensitized processes in collagen. J Biomed Opt. 2001;6:52–57
  45. Kielty CM, Sherratt MJ, Shuttleworth CA. Elastic fibres. J Cell Sci. 2002;115:2817–2828
  46. el-Far MA, Pimstone NR. The interaction of tumour-localizing porphyrins with collagen, elastin, gelatin, fibrin and fibrinogen. Cell Biochem Funct. 1985;3:115–119
  47. Grant WE, Speight PM, Hopper C, Bown SG. Photodynamic therapy: an effective, but non-selective treatment for superficial cancers of the oral cavity. Int J Cancer. 1997;71:937–942
  48. Miyazawa S, Nishida K, Komiyama T, et al. Novel transdermal photodynamic therapy using ATX-S10.Na(II) induces apoptosis of synovial fibroblasts and ameliorates collagen antibody-induced arthritis in mice. Rheumatol Int. 2006;26:717–725
  49. Heckenkamp J, Aleksic M, Gawenda M, et al. Modulation of human adventitial fibroblast function by photodynamic therapy of collagen matrix. Eur J Vasc Endovasc Surg. 2004;28:651–659

PII: S1572-1000(07)00030-0

doi: 10.1016/j.pdpdt.2007.02.002

Photodiagnosis and Photodynamic Therapy
Volume 4, Issue 2 , Pages 130-139 , June 2007

Article Tools

* Image Usage & Resolution